peptide elongation factor 2 has been researched along with Cancer of Gastrointestinal Tract in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, M; Miura, M; Tsuda-Sakurai, K | 1 |
| Aoyagi, S; Aozasa, K; Doki, Y; Fujiki, F; Fukuda, I; Fukuda, M; Hirata, E; Hosen, N; Mori, M; Nakamura, J; Nakatsuka, S; Nanchi, I; Nezu, R; Nishida, S; Nomura, M; Oji, Y; Oka, Y; Shibata, S; Shirakata, T; Sugiyama, H; Tatsumi, N; Tsuboi, A; Ueda, T; Yamamoto, Y | 1 |
2 other study(ies) available for peptide elongation factor 2 and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Diphthamide modification of eEF2 is required for gut tumor-like hyperplasia induced by oncogenic Ras.
Topics: Animals; Drosophila; Eating; Eukaryota; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Genes, ras; Histidine; Hyperplasia; Male; Peptide Elongation Factor 2; Protein Processing, Post-Translational; Ribosomes; Transcriptome | 2020 |
Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Cell Cycle; Cell Division; Female; G2 Phase; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Models, Biological; Peptide Elongation Factor 2; Tumor Cells, Cultured; Up-Regulation; Young Adult | 2009 |